Navigation Links
YORK Label Announces Continued Investment in the Company
Date:8/24/2009

OMAHA, Neb., Aug. 24 /PRNewswire/ -- YORK Label is pleased to announce that its private equity sponsor, Diamond Castle Holdings and the Company's Management Team have successfully acquired $32M of YORK Label senior and subordinated debt and renegotiated favorable new terms and conditions with its banking partners. The transaction was completed August 12th.

As a result of this transaction, overall debt for YORK Label is significantly reduced and cash flow is further improved. The company will continue to invest in technology and manufacturing assets which bring exceptional value to its customers and drive profitable growth for YORK Label.

Some recent examples of new investment by YORK Label include:

  • Acquisition of 3 brand new "state of the art" label printing presses in its flagship York, PA facility.
  • Establishment of pharmaceutical label capacity in the U.S., complementing the existing capability in Canada.
  • Facility investments to drive additional efficiency in its Canadian business.
  • Increased R&D spending to accelerate innovation with particular focus on graphic effects, environmental sustainability and late stage differentiation.

YORK Label President and CEO John McKernan comments, "This equity infusion will allow us to continue investing in new technology, new capacity, new capabilities, productivity improvement and strategic acquisitions. As an organization we are committed to executing our strategy to deliver exceptional quality, service and value to our customers in a sustainable manner."

About YORK Label

Omaha, NE based YORK Label is a leading provider of high quality, innovative labeling and package decoration solutions to global consumer products, wine and spirits, pharmaceutical and, food and beverage companies. YORK Label has production facilities throughout North America and a joint venture in Chile. The company employs more than 700 dedicated associates. For more information please visit www.yorklabel.com.

About Diamond Castle Holdings, LLC

Diamond Castle Holdings, LLC is a private equity firm with over $1.85 billion of committed capital under management. Founded in 2004, Diamond Castle specializes in leveraged buyouts, growth capital and equity-like investments in both public and private companies. Diamond Castle targets investments in the following industry sectors: media and communications, energy and power, financial services, healthcare and diversified industries. Diamond Castle has 25 employees located in New York, New York. For more information please visit www.dchold.com.


'/>"/>
SOURCE YORK Label
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Updated With Photos: NESTLE(R) TOLL HOUSE(R) Re-launches With New Batch Label
2. Update on Astellas Request for Rigorous Testing and Safety-Related Labeling for Anti-Rejection Medications
3. Astellas Seeks Rigorous Testing and Safety-Related Labeling for Anti-Rejection Medications
4. My1Stop.com Completes Upgrades to Prime Labels Offering and Easy Ordering Page Design
5. FDA Approves NovoLog(R) Labeling Update
6. Upsher-Smith Laboratories, Inc. Updates Prenexa.com with Folic Acid Content, Money-Saving Coupon, and Personalized Address Labels
7. Pre-cessation patch doubles quit success rate: Researchers call for labeling changes
8. Whole Foods Market(R) Partners With Non-GMO Project to Label Companys Private Label Food Products Using New Third-Party Standard
9. Analysis of drug-eluting stents data demonstrates safety, efficacy in on-and-off-label use
10. Asthma Drugs Get Precaution Labeling for Possible Psychiatric Side Effects
11. Statement by American Dietetic Association Supporting Scientifically Valid, Informative Restaurant Labeling as Part of Health Reform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... The Association of Healthcare and ... hold their first Northeast Regional AHVAP Meeting. For 2017, Dr. Hayes will provide ... and value analysis professionals have a ‘seat at the table’ with clinical committees ...
(Date:3/27/2017)... , ... March 27, 2017 , ... According to the ... cancer, including all stages, is more than 95%. Once the cancer spreads to other ... than 30%. To find out how to avoid this latter group, tune in to ...
(Date:3/27/2017)... ... March 27, 2017 , ... Sodium ... methods are complicated and require expert user knowledge. In a live webinar on ... to the simplified, yet highly accurate, determination of sodium. , It has long ...
(Date:3/27/2017)... ... March 27, 2017 , ... ?Grow Healthy Vending LLC announced ... litigation between itself and 1800 Vending DBA Healthy You Vending. (Civil No. 1:14-CV-00121-CW/ ... to announce that we have now reached a settlement agreement regarding the ongoing ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... deaths soared 167%,(1) with opioids alone responsible for over 33,000 of the 52,404 ... has sponsored Assembly Bill (AB) 1512, which proposes a tax on prescription opioids ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... --  Genprex, Inc. , a privately held, clinical-stage biopharmaceutical company developing ... Company,s Chief Operating Officer, is scheduled to present a corporate overview ... Annual Cancer BioPartnering & Investment Forum: Tuesday, March 28, 2017 at ... ... Annual Future Leaders in Biotech Industry – Friday, April 7, 2017 ...
(Date:3/27/2017)... -- Invivotek, LLC, a Genesis Biotechnology Group ® ... contract research organization (CRO), announced the completion of the ... research facility in Hamilton, New Jersey ... source to reduce costs and lessen the CRO facility,s ... Farm follows Invivotek,s recent expansion from a 19,712 square ...
(Date:3/24/2017)... Oregon and PUNE, India , March 24, 2017 /PRNewswire/ ... 2015, and is estimated to reach $2,614 million by 2022, Globally, registering a CAGR ... to generate the highest revenue, and is projected to dominate the market during the ... ... Allied Market Research Logo ...
Breaking Medicine Technology: